<ARTICLE>	6

<CIK>	0000320351

<NAME>	Fidelity Select Portfolios



	<NUMBER>	19

	<NAME>	Select-Biotechnology

<MULTIPLIER>	1,000







<PERIOD-TYPE>
6-MOS
<FISCAL-YEAR-END>
FEB-28-2001
<PERIOD-END>
AUG-31-2000
<INVESTMENTS-AT-COST>
3,565,616
<INVESTMENTS-AT-VALUE>
5,357,201
<RECEIVABLES>
94,977
<ASSETS-OTHER>
0
<OTHER-ITEMS-ASSETS>
0
<TOTAL-ASSETS>
5,452,178
<PAYABLE-FOR-SECURITIES>
39,243
<SENIOR-LONG-TERM-DEBT>
0
<OTHER-ITEMS-LIABILITIES>
487,357
<TOTAL-LIABILITIES>
526,600
<SENIOR-EQUITY>
0
<PAID-IN-CAPITAL-COMMON>
3,301,352
<SHARES-COMMON-STOCK>
50,429
<SHARES-COMMON-PRIOR>
49,339
<ACCUMULATED-NII-CURRENT>
(6,832)
<OVERDISTRIBUTION-NII>
0
<ACCUMULATED-NET-GAINS>
(160,527)
<OVERDISTRIBUTION-GAINS>
0
<ACCUM-APPREC-OR-DEPREC>
1,791,585
<NET-ASSETS>
4,925,578
<DIVIDEND-INCOME>
3,698
<INTEREST-INCOME>
8,320
<OTHER-INCOME>
1,282
<EXPENSES-NET>
20,132
<NET-INVESTMENT-INCOME>
(6,832)
<REALIZED-GAINS-CURRENT>
(142,070)
<APPREC-INCREASE-CURRENT>
(327,347)
<NET-CHANGE-FROM-OPS>
(476,249)
<EQUALIZATION>
0
<DISTRIBUTIONS-OF-INCOME>
0
<DISTRIBUTIONS-OF-GAINS>
95,481
<DISTRIBUTIONS-OTHER>
0
<NUMBER-OF-SHARES-SOLD>
25,551
<NUMBER-OF-SHARES-REDEEMED>
25,627
<SHARES-REINVESTED>
1,166
<NET-CHANGE-IN-ASSETS>
(366,772)
<ACCUMULATED-NII-PRIOR>
0
<ACCUMULATED-GAINS-PRIOR>
96,867
<OVERDISTRIB-NII-PRIOR>
0
<OVERDIST-NET-GAINS-PRIOR>
0
<GROSS-ADVISORY-FEES>
11,373
<INTEREST-EXPENSE>
0
<GROSS-EXPENSE>
20,251
<AVERAGE-NET-ASSETS>
3,976,801
<PER-SHARE-NAV-BEGIN>
107.270
<PER-SHARE-NII>
(.140)
<PER-SHARE-GAIN-APPREC>
(7.450)
<PER-SHARE-DIVIDEND>
0
<PER-SHARE-DISTRIBUTIONS>
2.110
<RETURNS-OF-CAPITAL>
0
<PER-SHARE-NAV-END>
97.670
<EXPENSE-RATIO>
99